Zoledronic acid is more efficient than ibandronic acid in the treatment of symptomatic bone marrow lesions of the knee

ConclusionZoledronic acid appeared to be more effective than other antiresorptive medications —at the cost of more frequent adverse events. While radiological and laboratory evaluation methods may allow for objective treatment monitoring, they appear to capture different dimensions than patient-reported pain.Level of evidenceIII.

Source: Knee Surgery, Sports Traumatology, Arthroscopy - July 3, 2019 Category: Orthopaedics Source Type: research